Enanta Pharmaceuticals
ENTA
ENTA
183 hedge funds and large institutions have $1.19B invested in Enanta Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 74 increasing their positions, 54 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
183
Holders Change
-14
Holders Change %
-7.11%
% of All Funds
4.08%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
24
Increased
74
Reduced
54
Closed
37
Calls
$4.56M
Puts
$4.43M
Net Calls
+$129K
Net Calls Change
-$1.2M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
$53M |
| 2 |
Morgan Stanley
New York
|
$13.6M |
| 3 |
Marshall Wace
London,
United Kingdom
|
$10.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$108M |
| 5 |
Citigroup
New York
|
$4.92M |
